CMS Scraps Biden Plan To Cover Anti-Obesity Medications

By Luke Zarzecki / April 4, 2025 at 5:56 PM

Updated Story The Trump administration will not move forward with a Biden administration proposal for CMS to cover anti-obesity medications. CMS excluded the language from the final contract year 2026 Medicare Part D rule out Friday (April 4). In its proposed rule, the Biden administration reinterpreted Medicare statute to allow coverage of anti-obesity medications (AOMs) for those with obesity by deeming it a chronic disease treatment under Medicare and Medicaid, but the Trump administration will not finalize...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

CMS Scraps Biden Plan To Cover Anti-Obesity Medications

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.